Reactions Weekly

, Volume 1159, Issue 1, pp 2–2 | Cite as

FDA investigates death after colistimethate inhalation

News item
  • 10 Downloads

Keywords

Cystic Fibrosis Respiratory Distress Respiratory Failure Acute Respiratory Distress Syndrome Cystic Fibrosis Patient 

REFERENCE

  1. 1.
    FDA.Information for healthcare professionals: colistimethate (marketed as Coly-Mycin M and generic products). Internet Document: [3 pages], 28 Jun 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations